PUBLISHER: Grand View Research | PRODUCT CODE: 1363537
PUBLISHER: Grand View Research | PRODUCT CODE: 1363537
U.S. Pharma E-commerce Market Size, Share & Trends Analysis Report By Product Type (Vaccines, Specialty Care), By Therapeutic Area (Diabetes, Immune-system Diseases), By Type, By Market Type, By Platform, And Segment Forecasts, 2023 - 2030
U.S. Pharma E-commerce Market Growth & Trends:
The U.S. pharma E-commerce market size is anticipated to reach USD 50.77 billion by 2030, growing at a CAGR of 19.8% from 2023 to 2030, according to a recent study by Grand View Research, Inc.. The increased usage of digital technology, which has made it easier for customers to acquire prescription medications online, is one of the primary drivers of this rise. Patients may now consult with healthcare specialists remotely and have their prescriptions filled through e-pharmacies, saving both time and effort, thanks to the advent of telemedicine and mobile health apps.
The COVID-19 pandemic hastened the transition toward online pharmaceutical purchasing, as many people seek to reduce their in-person encounters. This boom in e-pharmacy demand increased revenues and spurred the sector to spend extensively on enhancing logistics and supply chain infrastructure, ensuring that medications reach patients swiftly and safely. Furthermore, the competitive environment of the pharmaceutical e-commerce sector in the United States has changed dramatically. Established brick-and-mortar pharmacies have moved online, while startups and digital health platforms have grown in popularity. This fierce competition has fueled innovation, resulting in better user experiences, lower prices, and greater medicine pricing and availability transparency.
The U.S. pharmaceutical e-commerce sector is expected to expand further as customers become acclimated to the ease and efficiency of online drug purchasing. However, regulatory and cybersecurity issues must be addressed for this booming business to remain secure and reliable. As technology advances and customer preferences shift, the future of pharmaceutical e-commerce in the United States looks bright. Patients now have instant access to a wealth of drug information, including reviews, alternatives, and cost comparisons. This openness has enabled customers to make more educated healthcare decisions, leading to a surge in demand for individualized and customized drug solutions. E-pharmacies are reacting by providing services like medication synchronization, automated refills, and medication adherence programs to improve patient outcomes.
The expansion of the U.S. pharmaceutical e-commerce business is not restricted to prescription pharmaceuticals. Online purchases of over-the-counter (OTC) products, supplements, and healthcare-related items are also expanding. Because of this diversity of goods, e-pharmacies can now meet more healthcare demands, making them one-stop shopping for many customers. The ease of home delivery and the opportunity to compare pricing and read product evaluations make e-commerce platforms an appealing option for healthcare buying that extends beyond prescription pharmaceuticals.
However, as the sector grows, it confronts regulatory problems in privacy, data security, and prescription verification. Finding a happy medium between innovation and safety will be critical for long-term prosperity. The sector must address digital access and healthcare knowledge inequities to provide equal access to online pharmaceutical services. Despite these hurdles, the pharmaceutical e-commerce business in the United States shows no signs of slowing down, and its expansion promises to transform how Americans handle their healthcare requirements in the coming years.
U.S. Pharma E-commerce Market Report Highlights:
- The vaccine segment is projected to grow at the highest CAGR of over 21% from 2023 to 2030, owing to increased vaccination awareness and the convenience of online purchasing
- The diabetes segment is projected to witness the highest CAGR of around 23% from 2023 to 2030. The widespread availability of diabetes drugs on e-commerce platforms is expected to increase demand for diabetic medicines via e-commerce channels in the United States until 2030
- By type, the prescription medicine segment is projected to witness the highest CAGR of over 30% over the forecast period, owing to convenience and accessibility, telemedicine and digital health, cost savings, and increased health awareness
- By market type, the B2C segment is projected to witness the highest CAGR of over 21% over the forecast period. The ability to order prescription medications, healthcare products, and over-the-counter drugs from the comfort of one's home offers unmatched convenience, particularly for individuals with busy lifestyles or limited mobility
- By platform, the manufacturer-owned marketplace segment is projected to witness the highest CAGR of more than 22% over the forecast period. These marketplaces offer a direct-to-consumer model, which helps eliminate intermediaries, thereby reducing the cost for the manufacturers and customers
- The key players have wider sales channels, thereby driving the market's growth. Some major companies operating in the data center virtualization industry include Amazon.com, Inc.; Chewy, Inc.; CVS Health; Express Scripts; FSA Store Inc.; Healthwarehouse, Inc.; McKesson Corporation; OptumRx, Inc.; PillPack; Rite Aid Corp.; Sam's West, Inc.; The Kroger Co.; Walgreen Co.; Walmart Health; and 1-800 Contacts
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Methodology Segmentation & Scope
- 1.2. Information procurement
- 1.2.1. Purchased database
- 1.2.2. GVR's internal database
- 1.2.3. Secondary sources & third-party perspectives
- 1.2.4. Primary research
- 1.3. Information analysis
- 1.3.1. Data analysis models
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Pharma E-commerce Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.2. Industry Value Chain Analysis
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint/Challenge Analysis
- 3.3.3. Market Opportunity Analysis
- 3.4. Business Environment Analysis Tools
- 3.4.1. Porter's Five Forces Analysis
- 3.4.2. PEST Analysis
- 3.5. COVID-19 Impact Analysis
Chapter 4. U.S. Pharma E-commerce Market Product Type Outlook
- 4.1. U.S. Pharma E-commerce Market Share by Product Type, 2022 & 2030 (USD Billion)
- 4.2. Vaccines
- 4.2.1. Market size estimates and forecasts, 2018 - 2030 (USD Billion)
- 4.3. Specialty Care
- 4.3.1. Market estimates and forecast, 2018 - 2030 (USD Billion)
- 4.4. Topical Medicines
- 4.4.1. Market estimates and forecast, 2018 - 2030 (USD Billion)
- 4.5. Others
- 4.5.1. Market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 5. U.S. Pharma E-commerce Market Therapeutic Areas Outlook
- 5.1. U.S. Pharma E-commerce Market Share by Therapeutic Areas, 2022 & 2030 (USD Billion)
- 5.2. Diabetes
- 5.2.1. Market size estimates and forecasts, 2018 - 2030 (USD Billion)
- 5.3. Immune-system Diseases
- 5.3.1. Market estimates and forecast, 2018 - 2030 (USD Billion)
- 5.4. Cardiovascular Diseases
- 5.4.1. Market size estimates and forecasts, 2018 - 2030 (USD Billion)
- 5.5. Neurodegenerative Diseases
- 5.5.1. Market size estimates and forecasts, 2018 - 2030 (USD Billion)
- 5.6. Cancer
- 5.6.1. Market size estimates and forecasts, 2018 - 2030 (USD Billion)
- 5.7. HIV/AIDS
- 5.7.1. Market size estimates and forecasts, 2018 - 2030 (USD Billion)
- 5.8. Others
- 5.8.1. Market size estimates and forecasts, 2018 - 2030 (USD Billion)
Chapter 6. U.S. Pharma E-commerce Market Type Outlook
- 6.1. U.S. Pharma E-commerce Market Share by Type, 2022 & 2030 (USD Billion)
- 6.2. Prescription Medicine
- 6.2.1. Market size estimates and forecasts, 2018 - 2030 (USD Billion)
- 6.3. Over-the-Counter (OTC)
- 6.3.1. Market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 7. U.S. Pharma E-commerce Market Market Type Outlook
- 7.1. U.S. Pharma E-commerce Market Share by Market Type, 2022 & 2030 (USD Billion)
- 7.2. B2B
- 7.2.1. Market size estimates and forecasts, 2018 - 2030 (USD Billion)
- 7.3. B2B2B
- 7.3.1. Market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.4. B2B2C
- 7.4.1. Market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.5. B2C
- 7.5.1. Market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 8. U.S. Pharma E-commerce Market Platform Outlook
- 8.1. U.S. Pharma E-commerce Market Share by Platform, 2022 & 2030 (USD Billion)
- 8.2. Manufacturer-owned Digital Commerce
- 8.2.1. Market size estimates and forecasts, 2018 - 2030 (USD Billion)
- 8.3. Distributor/Wholesaler-owned Digital Commerce
- 8.3.1. Market estimates and forecast, 2018 - 2030 (USD Billion)
- 8.4. Manufacturer-owned Marketplace
- 8.4.1. Market estimates and forecast, 2018 - 2030 (USD Billion)
- 8.5. Third Party Market Place
- 8.5.1. Market estimates and forecast, 2018 - 2030 (USD Billion)
- 8.6. Retail
- 8.6.1. Market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 9. Competitive Landscape
- 9.1. Company Categorization (Mature Players, Emerging Players)
- 9.2. Company Share Analysis, 2022
- 9.3. Heat Map Analysis, 2022
- 9.4. Strategy Mapping
- 9.5. Company Profiles (Overview, Financial Performance, Product Overview, Strategic Initiatives)
- 9.5.1. Amazon.com, Inc.
- 9.5.2. Chewy, Inc.
- 9.5.3. CVS Health
- 9.5.4. Express Scripts
- 9.5.5. FSA Store Inc.
- 9.5.6. Healthwarehouse,.Inc
- 9.5.7. McKesson Corporation
- 9.5.8. OptumRx, Inc.
- 9.5.9. PillPack
- 9.5.10. Rite Aid Corp.
- 9.5.11. Sam's West, Inc.
- 9.5.12. The Kroger Co.
- 9.5.13. Walgreen Co.
- 9.5.14. Walmart Health
- 9.5.15. 1-800 Contacts
List of Tables
- Table 1 List of Abbreviations
- Table 2 U.S. Pharma E-commerce Market, by Product Type, 2018 - 2030 (USD Billion)
- Table 3 U.S. Pharma E-commerce Market, by Therapeutic Areas, 2018 - 2030 (USD Billion)
- Table 4 U.S. Pharma E-commerce Market, by Type, 2018 - 2030 (USD Billion)
- Table 5 U.S. Pharma E-commerce Market, by Market Type, 2018 - 2030 (USD Billion)
- Table 6 U.S. Pharma E-commerce Market, by Platform, 2018 - 2030, (USD Billion)
List of Figures
- Fig. 1 U.S. pharma E-commerce market segmentation
- Fig. 2 Methodology
- Fig. 3 Primary research pattern
- Fig. 4 Information analysis
- Fig. 5 Data analysis model
- Fig. 6 Data validation & publishing
- Fig. 7 U.S. pharma E-commerce market: Market snapshot
- Fig. 8 U.S. pharma E-commerce market: Segment snapshot
- Fig. 9 U.S. pharma E-commerce market: Competitive landscape snapshot
- Fig. 10 U.S. pharma E-commerce market Lineage outlook
- Fig. 11 U.S. pharma E-commerce market: Value chain analysis
- Fig. 12 Market driver analysis
- Fig. 13 Market restraint analysis
- Fig. 14 Market opportunity analysis
- Fig. 15 U.S. pharma E-commerce market: Porter's five forces analysis
- Fig. 16 U.S. pharma E-commerce market: PEST analysis
- Fig. 17 U.S. pharma E-commerce market analysis: Product Type segment analysis
- Fig. 18 U.S. pharma E-commerce market analysis: Therapeutic Areas segment analysis
- Fig. 19 U.S. pharma E-commerce market analysis: Type segment analysis
- Fig. 20 U.S. pharma E-commerce market analysis: Market Type segment analysis
- Fig. 21 U.S. pharma E-commerce market analysis: Platform segment analysis
